TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind episode artwork

EPISODE · Oct 25, 2023 · 1H 11M

TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind

from Next Sequence · host Vadim Nazarov, Loretta TIOIELA

ImmunoMind is a UC Berkeley SkyDeck alumnus company. ImmunoMind helps biotech companies understand crucial drug-human interactions, and transform the biodata chaos into more effective immunotherapies.

Episode metadata supplied by the publisher feed · Published Oct 25, 2023

Embed this episode

NOW PLAYING

TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind

0:00 1:11:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Next Sequence?

This episode is 1 hour and 11 minutes long.

When was this Next Sequence episode published?

This episode was published on October 25, 2023.

Can I download this Next Sequence episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!